Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


19.11.2018

1 Cancer
1 Cancer Lett
1 Curr Treat Options Oncol
1 Hum Pathol
1 Int J Cancer
1 Int J Oncol
1 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cancer

  1. SMITH HJ, McCaw TR, Londono AI, Katre AA, et al
    The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31761.
    PubMed     Text format     Abstract available


    Cancer Lett

  2. PENG Y, Kajiyama H, Yuan H, Nakamura K, et al
    PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.
    Cancer Lett. 2018;442:181-192.
    PubMed     Text format     Abstract available


    Curr Treat Options Oncol

  3. FAN CA, Reader J, Roque DM
    Review of Immune Therapies Targeting Ovarian Cancer.
    Curr Treat Options Oncol. 2018;19:74.
    PubMed     Text format     Abstract available


    Hum Pathol

  4. SEHOULI J, Braicu EI, Richter R, Denkert C, et al
    Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the tumor bank ovarian cancer network.
    Hum Pathol. 2018 Nov 11. pii: S0046-8177(18)30417.
    PubMed     Text format     Abstract available


    Int J Cancer

  5. SCHUBERT S, van Luttikhuizen JL, Auber B, Schmidt G, et al
    The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: high frequency of FANCM pathogenic variants.
    Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31992.
    PubMed     Text format     Abstract available


    Int J Oncol

  6. LI S, Zhao X, Chang S, Li Y, et al
    ERp57small interfering RNA silencing can enhance the sensitivity of drugresistant human ovarian cancer cells to paclitaxel.
    Int J Oncol. 2018 Nov 7. doi: 10.3892/ijo.2018.4628.
    PubMed     Text format     Abstract available


    Oncol Rep

  7. ALSAMMAN K, El-Masry OS
    Staurosporine alleviates cisplatin chemoresistance in human cancer cell models by suppressing the induction of SQSTM1/p62.
    Oncol Rep. 2018;40:2157-2162.
    PubMed     Text format     Abstract available


    PLoS One

  8. STARBUCK KD, Szender JB, Duncan WD, Morrell K, et al
    Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer.
    PLoS One. 2018;13:e0206913.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: